Record Q2 2016 Revenue of $44.5 million,
up 96% YOYQ2 2016 Earnings per
Share of $0.24Q2 2016 Adjusted
Earnings per Share of $0.27Record policies in
force totaled approximately 258,400, up 128%
YOYRevised 2016 guidance upward
Health Insurance Innovations, Inc. (HII) (NASDAQ:HIIQ), a leading
developer, distributor, and virtual administrator of affordable
health plans announced financial results for the second quarter
ended June 30, 2016. The Company will host a live conference
call on Tuesday, August 9, 2016 at 8:30 A.M. EST.
Second Quarter 2016 Consolidated Financial
Highlights
- Record revenue was $44.5 million, an increase of 95.6% over
$22.7 million in the second quarter of 2015.
- Record total collections from customers, which our industry
refers to as premium equivalents, of $77.0 million, an
increase of 99.8% over $38.5 million in the second quarter of
2015.
- Adjusted EBITDA (earnings before interest, taxes, depreciation
and amortization) was $6.5 million, compared to $1.8 million in the
second quarter of 2015.
- GAAP Net Income per diluted share for the second quarter of
2016 was $0.24, compared to negative $0.04 in the second quarter of
2015.
- Adjusted EPS, also referred to as Adjusted Net Income per
Share, was $0.27 in the second quarter of 2016 compared to $0.08 in
the second quarter of 2015.
- Record policies in force as of June 30, 2016, totaled
approximately 258,400, a 128% increase from 113,200 as of June 30,
2015.
See the reconciliations for premium equivalents, adjusted
EBITDA, and adjusted EPS within this press release.
Revised 2016 Full Year Guidance
For the full year 2016 we expect Revenue to grow between 48% and
58% year-over-year ($155 million to $165 million) and Adjusted EPS
to grow between 104% and 141% ($0.55 to $0.65).
Previously we guided to Revenue of $138 million to $144 million
and Adjusted EPS of $0.38 to $0.42.
"Our second quarter performance demonstrated continued strong
demand for our products with exceptional execution”
said Patrick McNamee, HII's Chief Executive Officer.
“AgileHealthInsurance.com, powered by the team at HealthPocket,
delivered the strongest revenue growth of all channels.
During the quarter, Agile sold approximately 16,000 STM policies
and a record 2,500 supplemental dental and vision policies.
Agile continues to be our largest distributor and will add new
products this year to assure future growth” said McNamee.
Regulatory Update
As mentioned in our June 9th 2016 press release, the Department
of Health and Human Services (HHS) proposed a rule that would limit
the duration of short-term, limited-duration health insurance. As
expected, there has been significant consumer and industry push
back. “We believe that HHS was well intentioned in their proposed
rule, however, it appears they have not fully appreciated the
negative impact their rule would have on consumers. The
proposed rule sets the stage for considerable consumer harm if
implemented without modification” said McNamee.
In Q2 the industry has seen increased regulatory scrutiny from
many states where we sell our products. In response to this we have
added additional resources to ensure continued responsiveness to
requests regarding our compliance processes. “We have always viewed
compliance as a critical pillar of our organization; integrity and
consumer satisfaction will always be a key element of our strategy”
said McNamee.
Second Quarter Financial Discussion
Second quarter revenues of $44.5 million increased by 95.6%, as
compared to the second quarter of 2015, driven primarily by an
increase in policies in force and continued strong sales in the
second quarter.
Adjusted gross margin in the second quarter, which is defined as
revenue less third-party commissions and credit card or ACH fees,
was up both year-over-year and sequentially to $17.7 million.
Adjusted gross margin as a percentage of premium equivalents in Q2
was 22.9%, down year-over-year but favorable sequentially.
The reduced gross margin percentage was driven by a revenue mix
shift in the quarter towards non-owned call centers and away from
owned call centers due to the restructuring of two of our owned
call centers in late 2015.
Total selling, general and administrative (“SG&A”) expenses
were $11.7 million (26.3% of revenues) in the second quarter of
2016, compared to $10.4 million (45.5% of revenues) in the same
period in 2015. Our core SGA for the quarter – total SGA less
marketing leads and advertising, stock compensation and
non-reoccurring costs – as a percentage of revenue was 19.5% in Q2
2016 compared to 32.7% in Q2 2015. Improvements in SG&A
for the quarter as percentage of revenue were realized due to our
continued focus on operational efficiencies.
EBITDA was $5.7 million in the second quarter of 2016, compared
to $0.6 million in the same period in 2015. Adjusted EBITDA
is calculated starting with EBITDA, which is then further adjusted
for items that are not part of regular operating activities,
including restructuring costs and other non-cash items such as
stock-based compensation. Adjusted EBITDA was $6.5 million in
the second quarter of 2016, compared to $1.8 million in the same
period in 2015. Adjusted EBITDA as a percentage of revenue
was 14.7% in the second quarter of 2016, compared to 7.9% in the
same period in 2015. A reconciliation of net income to EBITDA and
adjusted EBITDA for the 3 and 6 months ending June 30, 2016 and
2015 is included within this press release.
Adjusted EPS for Q2 2016 was $0.27 compared with $0.08 last
year.
The company makes short term loans to our distributors based on
actual sales that we refer to as “advance commissions”. The
advance commissions assist our distributors with cost of lead
acquisition and provide working capital. We recover the loans
from future commissions earned on premiums collected over the
period in which policies renew. The second quarter balance of
$32.8 million is a decrease of $3.8 million from the first quarter
of 2016.
Cash and cash equivalents totaled $9.3 million at the end of the
second quarter of 2016. Cash in Q2 increased by $2.4 million from
Q1 2016 which includes paying down $1.0 million of our bank line of
credit.
Conference Call and Webcast
The company will host an earnings conference call on August 9,
2016 at 8:30 A.M. Eastern time. All interested parties can
join the call by dialing (877) 407-9712; or (201) 689-8323;
the conference ID is 13640965. A webcast of the call
may be accessed in the Investor Relations section of Health
Insurance Innovations’ website at
http://investor.hiiquote.com/events.cfm. An archive of the
call will be available for 30 days through the same website.
About Health Insurance Innovations, Inc.
(HII)
HII is a market leader in developing innovative health insurance
products that are affordable and meet the needs of health insurance
plan shoppers. HII develops insurance products through partnerships
with best-in-class insurance companies and markets them via its
broad distribution network of licensed insurance agents across the
nation, its call center network and its unique online
capability. Additional information about HII can be found at
HiiQuote.com. HII’s Consumer Division includes
AgileHealthInsurance.com, a website for researching, comparing and
purchasing short-term health insurance products online and
HealthPocket.com, a free website that compares and ranks all health
insurance plans, and uses objective data to publish unbiased health
insurance market analyses and other consumer advocacy
research.
Forward-Looking Statements
This press release contains "forward-looking statements" within
the meaning of the U.S. Private Securities Litigation Reform Act of
1995. Forward-looking statements are statements other than
historical fact, and may include statements relating to goals,
plans and projections regarding new markets, products, services,
growth strategies, anticipated trends in our business and
anticipated changes and developments in the United States health
insurance system and laws. Forward-looking statements are based on
HII’s current assumptions, expectations and beliefs are generally
identifiable by use of words “may,” “might,” “will,” “should,”
“expects,” “plans,” “anticipates,” “believes,” “estimates,”
“predicts,” “potential” or “continue,” or similar expressions and
involve significant risks and uncertainties that could cause actual
results, developments and business decisions to differ materially
from those contemplated by these statements. These risks and
uncertainties include, among other things, our ability to maintain
relationships and develop new relationships with health insurance
carriers and distributors, our ability to retain our members, the
demand for our products, the amount of commissions paid to us or
changes in health insurance plan pricing practices, our ability to
integrate our acquisitions (including our July 2014 acquisition of
HealthPocket, Inc.), competition, changes and developments in the
United States health insurance system and laws, and HII’s ability
to adapt to them, the ability to maintain and enhance our name
recognition, difficulties arising from acquisitions or other
strategic transactions, and our ability to build the necessary
infrastructure and processes to maintain effective controls over
financial reporting. These and other risk factors that could cause
actual results to differ materially from those expressed or implied
in our forward-looking statements are discussed in HII's most
recent Annual Report on Form 10-K filed with the Securities and
Exchange Commission (SEC) as well as other documents that may be
filed by HII from time to time with the Securities and Exchange
Commission, which are available at www.sec.gov. Any forward-looking
statement made by us in this press release is based only on
information currently available to us and speaks only as of the
date on which it is made. You should not rely on any
forward-looking statement as representing our views in the future.
We undertake no obligation to publicly update any forward-looking
statement, whether written or oral, that may be made from time to
time, whether as a result of new information, future developments
or otherwise.
HEALTH INSURANCE
INNOVATIONS, INC. |
|
Condensed
Consolidated Balance Sheets |
($ in thousands,
except share and per share data) |
|
|
June 30, 2016 |
|
December 31, 2015 |
|
(unaudited) |
|
|
Assets |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
$ |
9,269 |
|
|
$ |
7,695 |
|
Restricted cash |
|
15,682 |
|
|
|
7,906 |
|
Accounts receivable, net, prepaid
expenses and other current assets |
|
1,478 |
|
|
|
1,778 |
|
Advanced commissions, net |
|
32,803 |
|
|
|
24,531 |
|
Income taxes receivable |
— |
|
|
|
591 |
|
Total current
assets |
|
59,232 |
|
|
|
42,501 |
|
Property and equipment,
net |
|
3,205 |
|
|
|
2,004 |
|
Goodwill |
|
41,076 |
|
|
|
41,076 |
|
Intangible assets,
net |
|
8,946 |
|
|
|
10,061 |
|
Other assets |
|
264 |
|
|
|
142 |
|
Total assets |
$ |
112,723 |
|
|
$ |
95,784 |
|
Liabilities and
stockholders’ equity |
|
|
|
Current
liabilities: |
|
|
|
Accounts payable and accrued
expenses |
$ |
21,096 |
|
|
$ |
17,847 |
|
Deferred revenue |
|
160 |
|
|
|
384 |
|
Current portion of contingent
acquisition consideration |
— |
|
|
|
532 |
|
Income taxes payable |
|
296 |
|
|
— |
|
Due to member |
|
790 |
|
|
|
342 |
|
Other current liabilities |
|
211 |
|
|
|
203 |
|
Total current
liabilities |
|
22,553 |
|
|
|
19,308 |
|
Revolving line of
credit |
|
14,000 |
|
|
|
7,500 |
|
Deferred tax
liability |
|
109 |
|
|
|
358 |
|
Due to member |
|
387 |
|
|
|
406 |
|
Other liabilities |
|
186 |
|
|
|
158 |
|
Total liabilities |
|
37,235 |
|
|
|
27,730 |
|
Commitments and
contingencies |
|
|
|
Stockholders’
equity: |
|
|
|
Class A common
stock (par value $0.001 per share, 100,000,000 shares authorized;
7,910,086 and 7,910,086 shares issued, respectively; and 7,791,225
and 7,759,092 shares outstanding, respectively) |
|
8 |
|
|
|
8 |
|
Class B common stock
(par value $0.001 per share, 20,000,000 shares authorized;
6,841,667 shares issued and outstanding, respectively) |
|
7 |
|
|
|
7 |
|
Preferred stock (par
value $0.001 per share, 5,000,000 shares authorized; no shares
issued and outstanding) |
— |
|
|
— |
|
Additional paid-in
capital |
|
45,185 |
|
|
|
44,591 |
|
Treasury stock, at cost
(118,860 and 150,993 shares, respectively) |
|
(1,190 |
) |
|
|
(1,542 |
) |
Accumulated
deficit |
|
(331 |
) |
|
|
(3,093 |
) |
Total Health Insurance Innovations,
Inc. stockholders’ equity |
|
43,679 |
|
|
|
39,971 |
|
Noncontrolling
interests |
|
31,809 |
|
|
|
28,083 |
|
Total stockholders’ equity |
|
75,488 |
|
|
|
68,054 |
|
Total liabilities and stockholders'
equity |
$ |
112,723 |
|
|
$ |
95,784 |
|
HEALTH INSURANCE
INNOVATIONS, INC. |
|
Condensed
Consolidated Statements of Operations (unaudited) |
($ in thousands,
except share and per share data) |
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
2016 |
|
|
|
2015 |
|
|
|
2016 |
|
|
|
2015 |
|
Revenues (premium
equivalents of $76,977 and $38,531 for the three months ended June
30, 2016 and 2015, respectively and $147,717 and $76,812 for the
six months ended June 30, 2016 and 2015, respectively) |
$ |
44,494 |
|
|
$ |
22,747 |
|
|
$ |
86,984 |
|
|
$ |
45,288 |
|
Operating
expenses: |
|
|
|
|
|
|
|
Third-party commissions |
|
25,859 |
|
|
|
11,260 |
|
|
|
51,849 |
|
|
|
22,094 |
|
Credit card and ACH fees |
|
974 |
|
|
|
527 |
|
|
|
1,857 |
|
|
|
1,012 |
|
Selling, general and
administrative |
|
11,697 |
|
|
|
10,351 |
|
|
|
23,667 |
|
|
|
21,515 |
|
Depreciation and amortization |
|
797 |
|
|
|
784 |
|
|
|
1,532 |
|
|
|
1,568 |
|
Total operating expenses |
|
39,327 |
|
|
|
22,922 |
|
|
|
78,905 |
|
|
|
46,189 |
|
Income (loss) from operations |
|
5,167 |
|
|
|
(175 |
) |
|
|
8,079 |
|
|
|
(901 |
) |
|
|
|
|
|
|
|
|
Other (income)
expense: |
|
|
|
|
|
|
|
Interest expense (income) |
|
100 |
|
|
|
(10 |
) |
|
|
155 |
|
|
|
(17 |
) |
Fair value adjustment to contingent
acquisition consideration |
|
15 |
|
|
|
105 |
|
|
|
15 |
|
|
|
(386 |
) |
Other expense (income) |
|
245 |
|
|
|
(105 |
) |
|
|
432 |
|
|
|
(253 |
) |
Net income (loss)
before income taxes |
|
4,807 |
|
|
|
(165 |
) |
|
|
7,477 |
|
|
|
(245 |
) |
Provision for income taxes |
|
537 |
|
|
|
373 |
|
|
|
921 |
|
|
|
37 |
|
Net income (loss) |
|
4,270 |
|
|
|
(538 |
) |
|
|
6,556 |
|
|
|
(282 |
) |
Net income (loss) attributable to
noncontrolling interests |
|
2,413 |
|
|
|
(212 |
) |
|
|
3,794 |
|
|
|
(9 |
) |
Net income (loss)
attributable to Health Insurance Innovations, Inc. |
$ |
1,857 |
|
|
$ |
(326 |
) |
|
$ |
2,762 |
|
|
$ |
(273 |
) |
|
|
|
|
|
|
|
|
Per share
data: |
|
|
|
|
|
|
|
Net income
(loss) per share attributable to Health Insurance
Innovations, Inc. |
|
|
|
|
|
|
|
Basic |
$ |
0.24 |
|
|
$ |
(0.04 |
) |
|
$ |
0.36 |
|
|
$ |
(0.04 |
) |
Diluted |
$ |
0.24 |
|
|
$ |
(0.04 |
) |
|
$ |
0.36 |
|
|
$ |
(0.04 |
) |
Weighted
average Class A common shares outstanding |
|
|
|
|
|
|
|
Basic |
|
7,592,972 |
|
|
|
7,516,308 |
|
|
|
7,578,264 |
|
|
|
7,515,684 |
|
Diluted |
|
7,732,664 |
|
|
|
7,516,308 |
|
|
|
7,716,202 |
|
|
|
7,515,684 |
|
Reconciliation
of Net Income to EBITDA and Adjusted EBITDA |
(unaudited) |
($ in
thousands) |
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
2016 |
|
|
|
2015 |
|
|
|
2016 |
|
|
|
2015 |
|
Net income (loss) |
$ |
4,270 |
|
|
$ |
(538 |
) |
|
$ |
6,556 |
|
|
$ |
(282 |
) |
Interest expense (income) |
|
100 |
|
|
|
(10 |
) |
|
|
155 |
|
|
|
(17 |
) |
Depreciation and amortization |
|
797 |
|
|
|
784 |
|
|
|
1,532 |
|
|
|
1,568 |
|
Provision for income taxes |
|
537 |
|
|
|
373 |
|
|
|
921 |
|
|
|
37 |
|
EBITDA |
|
5,704 |
|
|
|
609 |
|
|
|
9,164 |
|
|
|
1,306 |
|
Non-cash stock-based compensation |
|
482 |
|
|
|
626 |
|
|
|
969 |
|
|
|
687 |
|
Fair value adjustment to contingent
consideration |
|
15 |
|
|
|
105 |
|
|
|
15 |
|
|
|
(386 |
) |
Transaction costs |
— |
|
|
— |
|
|
— |
|
|
|
24 |
|
Tax receivable agreement liability
adjustment |
|
244 |
|
|
|
(19 |
) |
|
|
429 |
|
|
|
106 |
|
Other non-recurring charges |
|
103 |
|
|
|
468 |
|
|
|
222 |
|
|
|
398 |
|
Adjusted EBITDA |
$ |
6,548 |
|
|
$ |
1,789 |
|
|
$ |
10,799 |
|
|
$ |
2,135 |
|
Reconciliation
of Net Income to Adjusted Net Income per Share |
(Unaudited) |
($ in
thousands except per share data) |
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
2016 |
|
|
|
2015 |
|
|
|
2016 |
|
|
|
2015 |
|
Net income (loss) |
$ |
4,270 |
|
|
$ |
(538 |
) |
|
$ |
6,556 |
|
|
$ |
(282 |
) |
Interest expense (income) |
|
100 |
|
|
|
(10 |
) |
|
|
155 |
|
|
|
(17 |
) |
Amortization |
|
557 |
|
|
|
784 |
|
|
|
1,115 |
|
|
|
1,472 |
|
Provision for income taxes |
|
537 |
|
|
|
373 |
|
|
|
921 |
|
|
|
37 |
|
Non-cash stock-based compensation |
|
482 |
|
|
|
626 |
|
|
|
969 |
|
|
|
687 |
|
Fair value adjustment to contingent
consideration |
|
15 |
|
|
|
105 |
|
|
|
15 |
|
|
|
(386 |
) |
Transaction costs |
— |
|
|
— |
|
|
— |
|
|
|
24 |
|
Tax receivable agreement liability
adjustment |
|
244 |
|
|
|
(19 |
) |
|
|
429 |
|
|
|
106 |
|
Other non-recurring charges |
|
103 |
|
|
|
468 |
|
|
|
222 |
|
|
|
398 |
|
Adjusted pre-tax income |
|
6,308 |
|
|
|
1,789 |
|
|
|
10,382 |
|
|
|
2,039 |
|
Pro forma income
taxes |
|
(2,397 |
) |
|
|
(680 |
) |
|
|
(3,945 |
) |
|
|
(775 |
) |
Adjusted net income |
$ |
3,911 |
|
|
$ |
1,109 |
|
|
$ |
6,437 |
|
|
$ |
1,264 |
|
Total weighted average
diluted share count |
|
14,575 |
|
|
|
14,358 |
|
|
|
14,558 |
|
|
|
14,358 |
|
Adjusted net income per
share |
$ |
0.27 |
|
|
$ |
0.08 |
|
|
$ |
0.44 |
|
|
$ |
0.09 |
|
(1) EBITDA is defined as net income before interest expense,
income taxes and depreciation and amortization. We have included
EBITDA in this report because it is a key measure used by our
management and Board of Directors to understand and evaluate our
core operating performance and trends, to prepare and approve our
annual budget and to develop short- and long-term operational
plans. In particular, the exclusion of certain expenses in
calculating EBITDA can provide a useful measure for
period-to-period comparisons of our business. However, EBITDA does
not represent, and should not be considered as, an alternative to
net income or cash flows from operations, each as determined in
accordance with generally accepted accounting principles in the
United States of America (“GAAP”). Other companies may calculate
EBITDA differently than we do. EBITDA has limitations as an
analytical tool, and you should not consider it in isolation or as
a substitute for analysis of our results as reported under
GAAP.
(2) To calculate adjusted EBITDA, we calculate EBITDA, which is
then further adjusted for items that are not part of regular
operating activities, including acquisition costs, and other
non-cash items such as non-cash stock-based compensation. Adjusted
EBITDA does not represent, and should not be considered as, an
alternative to net income or cash flows from operations, each as
determined in accordance with GAAP. We have presented adjusted
EBITDA because we consider it an important supplemental measure of
our performance and believe that it is frequently used by analysts,
investors and other interested parties in the evaluation of
companies. Other companies may calculate adjusted EBITDA
differently than we do. Adjusted EBITDA has limitations as an
analytical tool, and you should not consider it in isolation or as
a substitute for analysis of our results as reported under
GAAP.
(3) To calculate adjusted net income, we calculate net income
then add back amortization (but not depreciation), interest, tax
expense and other items that are not part of regular operating
activities, including acquisition costs, restructuring costs,
contract termination costs, tax receivable agreement liability
adjustments, and other non-cash items such as non-cash stock-based
compensation and fair value adjustment to contingent consideration.
From adjusted pre-tax net income we apply a pro forma tax expense
calculated at an assumed rate of 38%. We believe that when
measuring Company and executive performance against the adjusted
net income measure, applying a pro forma tax rate better reflects
the performance of the Company without regard to the Company’s
organizational tax structure. We have included adjusted net income
in this report because it is a key performance measure used by our
management to understand and evaluate our core operating
performance and trends and because we believe it is frequently used
by analysts, investors and other interested parties in their
evaluation of our company. Other companies may calculate this
measure differently than we do. Adjusted net income has limitations
as an analytical tool, and you should not consider it in isolation
or substitution for earnings per share as reported under GAAP.
(4) Adjusted net income per share is computed by dividing
adjusted net income by the total number of diluted Class A and
Class B shares of our common stock for each period. We have
included adjusted net income per share in this report because it is
a key measure used by our management to understand and evaluate our
core operating performance and trends and because we believe it is
frequently used by analysts, investors and other interested parties
in the evaluation of companies. Other companies may calculate this
measure differently than we do. Adjusted net income per share has
limitations as an analytical tool, and you should not consider it
in isolation or as a substitute for earnings per share as reported
under GAAP.
Reconciliation
of Premium Equivalents to Revenues & Adjusted Gross
Margin |
(unaudited) |
($ in
thousands) |
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
2016 |
|
|
|
2015 |
|
|
|
2016 |
|
|
|
2015 |
|
Premium
equivalents |
$ |
76,977 |
|
|
$ |
38,531 |
|
|
$ |
147,717 |
|
|
$ |
76,812 |
|
Less risk premium |
|
30,942 |
|
|
|
14,962 |
|
|
|
57,824 |
|
|
|
29,868 |
|
Less amounts earned by third party
obligors |
|
1,541 |
|
|
|
822 |
|
|
|
2,909 |
|
|
|
1,656 |
|
Revenues |
|
44,494 |
|
|
|
22,747 |
|
|
|
86,984 |
|
|
|
45,288 |
|
Third-party commissions |
|
25,859 |
|
|
|
11,260 |
|
|
|
51,849 |
|
|
|
22,094 |
|
Credit card and ACH fees |
|
974 |
|
|
|
527 |
|
|
|
1,857 |
|
|
|
1,012 |
|
Adjusted gross
margin |
$ |
17,661 |
|
|
$ |
10,960 |
|
|
$ |
33,278 |
|
|
$ |
22,182 |
|
(1) Premium equivalents is defined as the combination of
premiums, fees for discount benefit plans (a non-insurance benefit
product that supplements or enhances an insurance product), fees
for distributors, our enrollment fees and third-party commissions
and referral fees. From premium equivalents, we remit risk premium
to carriers and amounts earned by discount benefit plan providers,
who we refer to as third-party obligors, such carriers and
third-party obligors being the ultimate parties responsible for
providing the insurance coverage or discount benefits to the
member. Our revenues consist of the balance of the premium
equivalents. We have included premium equivalents in this report
because it is a key measure used by our management to understand
and evaluate our core operating performance and trends, to prepare
and approve our annual budget and to develop short- and long-term
operational plans. In particular, the inclusion of premium
equivalents can provide a useful measure for period-to-period
comparisons of our business. This financial measurement is
considered a non-GAAP financial measure and is not recognized under
GAAP and should not be used as, and is not an alternative to,
revenues as a measure of our operating performance.
(2) Adjusted gross margin is defined as revenues less third
party commissions and credit card and ACH fees. Adjusted
gross margin does not represent, and should not be considered as,
an alternative to revenues, as determined in accordance with GAAP.
Adjusted gross margin is a key measure used by our management to
understand and evaluate our core operating performance and trends,
to prepare and approve our annual budget and to develop short-term
and long-term operational plans. In particular, adjusted gross
margin can provide a useful measure for period-to-period
comparisons of our business. Adjusted gross margin has limitations
as an analytical tool, and you should not consider it in isolation
or as a substitute for analysis of our results as reported under
GAAP.
Summary of
selected metrics |
(unaudited) |
($ in
thousands) |
|
|
Submitted Applications during Three Months Ended
June 30, |
|
|
|
|
2016 |
|
|
2015 |
|
Change (%) |
IFP |
|
65,000 |
|
|
|
32,000 |
|
|
103 |
% |
|
Supplemental products |
|
62,600 |
|
|
|
31,700 |
|
|
97 |
% |
|
Total |
|
127,600 |
|
|
|
63,700 |
|
|
100 |
% |
|
|
Policies in Force as of June
30, |
|
|
|
|
2016 |
|
|
2015 |
|
|
Change (%) |
|
IFP |
|
120,900 |
|
|
|
50,700 |
|
|
|
|
139 |
% |
|
Supplemental
products |
|
137,500 |
|
|
|
62,500 |
|
|
|
|
120 |
% |
|
Total |
|
258,400 |
|
|
|
113,200 |
|
|
|
|
128 |
% |
|
|
Submitted IFP Applications by
Channel |
|
Q2'15 |
|
Q3'15 |
|
Q4'15 |
|
Q1’16 |
|
Q2’16 |
Agile |
300 |
|
5,800 |
|
11,300 |
|
23,100 |
|
16,000 |
All Others |
31,700 |
|
39,100 |
|
57,900 |
|
72,300 |
|
49,000 |
Total |
32,000 |
|
44,900 |
|
69,200 |
|
95,400 |
|
65,000 |
|
Core SG&A as a Percentage of Revenue |
|
Q2'15 |
|
Q3'15 |
|
Q4'15 |
|
Q1’16 |
|
Q2’16 |
Total SG&A |
$ |
10,350 |
|
|
$ |
10,845 |
|
|
$ |
14,964 |
|
|
$ |
11,970 |
|
|
$ |
11,697 |
|
Less: Stock-based compensation |
|
626 |
|
|
|
313 |
|
|
|
363 |
|
|
|
486 |
|
|
|
482 |
|
Less: Other non-recurring
charges |
|
468 |
|
|
|
273 |
|
|
|
2,952 |
|
|
|
119 |
|
|
|
103 |
|
Less: Marketing and
Advertising |
|
1,809 |
|
|
|
2,305 |
|
|
|
3,046 |
|
|
|
2,820 |
|
|
|
2,449 |
|
Core SG&A |
$ |
7,447 |
|
|
$ |
7,954 |
|
|
$ |
8,603 |
|
|
$ |
8,545 |
|
|
$ |
8,663 |
|
% of Revenue |
|
32.7 |
% |
|
|
30.8 |
% |
|
|
25.6 |
% |
|
|
20.1 |
% |
|
|
19.5 |
% |
CONTACTS:
Health Insurance Innovations, Inc.:Michael HershbergerChief
Financial Officer(877) 376-5831 ext.
282mhershberger@hiiquote.com
Investor Contact:Investor Relations office(813)
452-5221IR@hiiquote.com
Media Contact for AgileHealthInsurance &
HealthPocket.com:Amy
Fletcher720-350-3144info@afmcommunications.com
Health Insurance Innovat... (NASDAQ:HIIQ)
Gráfico Histórico do Ativo
De Set 2024 até Out 2024
Health Insurance Innovat... (NASDAQ:HIIQ)
Gráfico Histórico do Ativo
De Out 2023 até Out 2024